Regeneron says U.S. government to buy 1.25 million doses of its COVID-19 treatmentMarket Watch • 01/12/21
Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail DosesPRNewsWire • 01/12/21
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)Seeking Alpha • 01/11/21
Regeneron's Antibodies Appear to Help Hospitalized Patients—and Could Help 2021 RevenueBarrons • 12/30/20
Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive resultsMarket Watch • 12/30/20
Regeneron COVID-19 Antibody Cocktail Shows Positive Response In Hospitalized PatientsBenzinga • 12/30/20
Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow OxygenPRNewsWire • 12/29/20
New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19PRNewsWire • 12/17/20
Goldman Sachs Adds Pharmaceutical Giant to Conviction List of Top Stocks to Buy24/7 Wall Street • 12/16/20
Regeneron Announces Presentation at the 39th Annual J.P. Morgan Healthcare ConferencePRNewsWire • 12/16/20